1,1-Bis(tert-butylperoxy)cyclohexane
Common Name: |
1,1-Bis(tert-butylperoxy)cyclohexane |
IUPAC Name: |
1,1-bis(tert-butylperoxy)cyclohexane |
Molecular Formula: |
C14H28O4 |
SMILES: |
CC(C)(C)OOC1(CCCCC1)OOC(C)(C)C |
Inchi: |
1S/C14H28O4/c1-12(2,3)15-17-14(10-8-7-9-11-14)18-16-13(4,5)6/h7-11H2,1-6H3 |
Inchi Key: |
HSLFISVKRDQEBY-UHFFFAOYSA-N |
Cas No: |
3006-86-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
260.37 |
Mass (g/mol) |
260.199 |
Molar Refractivity |
71.75 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
36.92 |
Hetero Atoms |
4 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
4.14 |
iLOGP |
3.84 |
XLOGP3 |
3.72 |
WLOGP |
4.14 |
MLOGP |
2.93 |
ESOL Log S |
-3.40 |
ESOL Solubility (mg/ml) |
0.103 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.19 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.92 |
Silicos-IT Solubility (mg/ml) |
0.31 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.25 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.934 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.226 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |